Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Cell Genesys and EntreMed sign antiangiogenesis gene therapy agreement

Aug. 23, 1999

Agouron commences phase III trial of prinomastat for treatment of lung cancer

Aug. 20, 1999

Chugai continues to investigate new vitamin D compounds

Aug. 20, 1999

Yakult Honsha discloses potent and water-soluble taxane derivatives

Aug. 20, 1999

Aronex expands Atragen phase II clinical trial in prostate cancer

Aug. 19, 1999

Pasteur Merieux Connaught and Zycos collaborate on cancer vaccine research

Aug. 18, 1999

Cytran and Alza enter agreement for IM-862

Aug. 18, 1999

Ribozyme presents positive data on Angiozyme cancer therapy

Aug. 18, 1999

Millennium reaches milestone in cancer collaboration with Lilly

Aug. 18, 1999

Rhone-Poulenc Rorer identifies new farnesyltransferase inhibitor series

Aug. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...